Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.41 |
| ▸ | JUN | P05412 | 2/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.41 |
| ▸ | RELA | Q04206 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATF1 | P18846 | 1/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27838050 | 0.90 | KDM4E (0.50) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL124869 | 0.88 | MAPT (0.40) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL125663 | 0.86 | KDM4E (0.53) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL128050 | 0.85 | KDM4E (0.48) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL127103 | 0.85 | IDO1 (0.53) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL123322 | 0.84 | KDM4E (0.53) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL122615 | 0.84 | KDM4E (0.51) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL30813138 | 0.84 | KDM4E (0.53) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL123367 | 0.83 | KDM4E (0.53) | KDM4ENPSR1IDO1MAPTALDH1A1 | |
| SCHEMBL123713 | 0.83 | KDM4E (0.50) | KDM4ENPSR1IDO1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461083-B2 | Herbicidal compounds | SYNGENTA LIMITED (GB) | 2013-06-11 | — | — | US | disclosed |
| EP-2265120-B1 | HERBICIDAL COUMPOUNDS | SYNGENTA LTD (GB) | 2012-03-07 | — | — | EP | disclosed |
| US-20110021352-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021352-A1 | HERBICIDAL COMPOUNDS | RDX, NQO2, DDT | KDM4E 1231/4885NPSR1 683/4885IDO1 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.